Equities

XWELL Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

XWELL Inc

Actions
Consumer DiscretionaryTravel and Leisure
  • Price (USD)0.4414
  • Today's Change-0.028 / -5.88%
  • Shares traded222.89k
  • 1 Year change-62.59%
  • Beta1.4193
Data delayed at least 15 minutes, as of Feb 13 2026 20:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

XWELL, Inc. is a global wellness holding company. The Company operates through four segments: XpresSpa, XpresTest, Naples Wax Center and Treat. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresCheck segment, in partnership with the Centers for Disease Control and Prevention (CDC) and Ginkgo Biosecurity, conducts biosurveillance monitoring in its airport locations. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers.

  • Revenue in USD (TTM)29.52m
  • Net income in USD-17.40m
  • Incorporated2006
  • Employees246.00
  • Location
    XWELL Inc254 WEST 31ST STREET, 11TH FLOORNEW YORK 10001United StatesUSA
  • Phone+1 (212) 750-9595
  • Fax+1 (302) 636-5454
  • Websitehttps://www.xwell.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
All American Gold Corp0.00-53.03k1.50m0.00---------0.0006-0.00060.00-0.00090.00-------455.19-4,464.36---------------22.25--------96.82------
Xwell Inc29.52m-17.40m2.55m246.00------0.0862-3.27-3.275.44-1.041.0640.1924.63120,016.30-52.18-45.38-163.70-61.9719.3426.42-49.07-82.401.02--0.00--12.58-6.9239.25---4.66--
Family Office of America Inc0.00-279.91k9.09m0.00--11.31-----0.0115-0.01150.000.02710.00-------63.90---69.06--------------0.00------87.52------
Medirom Healthcare Technologies Inc(ADR)52.84m265.08k10.51m334.0010.04--4.210.19890.13250.13257.19--1.1736.0612.63158,196.000.5151-3.581.35-7.4825.0524.530.4413-3.660.2082-5.130.7982--21.5516.2528.9153.71115.80--
Data as of Feb 13 2026. Currency figures normalised to XWELL Inc's reporting currency: US Dollar USD

Institutional shareholders

5.19%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 202582.69k1.43%
The Vanguard Group, Inc.as of 31 Dec 202551.31k0.89%
Geode Capital Management LLCas of 30 Sep 202546.93k0.81%
Iroquois Capital Management LLCas of 06 Nov 202528.79k0.50%
G1 Execution Services LLCas of 30 Sep 202525.51k0.44%
Vanguard Fiduciary Trust Co.as of 31 Dec 202523.38k0.41%
SSgA Funds Management, Inc.as of 30 Sep 202516.14k0.28%
Integrated Wealth Concepts LLCas of 30 Sep 202510.35k0.18%
Ground Swell Capital LLCas of 31 Dec 202510.21k0.18%
Tower Research Capital LLCas of 30 Sep 20253.77k0.07%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.